Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer’s Disease and Future PerspectivesNatália Moreira, Elza Tiemi Sakamoto‐Hojo, Ivone Carvalho et al.|Journal of Alzheimer s Disease Reports|2022Cited by 106
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's diseaseTalita P.C. Chierrito, Ivone Carvalho, Natália Moreira et al.|European Journal of Medicinal Chemistry|2017Cited by 54
Galanthamine decreases genotoxicity and cell death induced by β-amyloid peptide in SH-SY5Y cell lineWillian Orlando Castillo Ordoñez, Catarina Satie Takahashi, Andrés Felipe Aristizábal-Pachón et al.|NeuroToxicology|2016Cited by 43
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's diseasePeterson de Andrade, Ivone Carvalho, Susimaire P. Mantoani et al.|Bioorganic & Medicinal Chemistry|2018Cited by 42
Exploration of the Acetylcholinesterase Inhibitory Activity of Some Alkaloids from Amaryllidaceae Family by Molecular Docking In SilicoSilvana Giuliatti, Elvira Regina Tamarozzi, Gabriel Monteiro da Silva et al.|Neurochemical Research|2017Cited by 24